NCT05743504View on ClinicalTrials.gov

Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

November 30, 2025

Conditions
Locally Advanced Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Tiragolumab

Neoadjuvant Tiragolumab, Atezolizumab, Paclitaxel, Cisplatin and Radiotherapy Followed by Surgery

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER